HomeInsights52 Week High Stocks

Concord Biotech Ltd 52 Week High

Concord Biotech Ltd 52 Week High

stocks purchased

₹ 0.7 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

3.3 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 22, 2024

Image

Concord Biotech Ltd

NSE: CONCORDBIO

YEARHIGH

₹ 2658

Last updated on: Nov 22, 2024

Key Highlights

  • The 52 Week HIGH of Concord Biotech Ltd is ₹ 2658 as of 22 Nov 24 .

Company Fundamentals for Concord Biotech Ltd

No data available

Market Price of Concord Biotech Ltd

1M

1Y

3Y

5Y

Monitoring Concord Biotech Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 20242031.55
21 Nov 20241988.55
19 Nov 20241898.5
18 Nov 20241910.05
14 Nov 20241893.25
13 Nov 20241853.45
12 Nov 20241860.35
11 Nov 20241877.85
08 Nov 20241851.85
07 Nov 20241828.7

Asset Value vs Market Value of Concord Biotech Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Concord Biotech Ltd

No data available

* All values are in crore

Historical Net Profit of Concord Biotech Ltd

No data available

* All values are in crore

Concord Biotech Ltd News Hub

News

Concord Biotech to conduct board meeting

Concord Biotech will hold a meeting of the Board of Directors of the Company on 11 Novembe...

Read more

06 Nov 202409:53

News

Volumes jump at Concord Biotech Ltd counter

K E C International Ltd, Sonata Software Ltd, TV18 Broadcast Ltd, ZF Commercial Vehicle Co...

Read more

29 Aug 202414:30

News

Concord Biotech schedules board meeting

Concord Biotech will hold a meeting of the Board of Directors of the Company on 9 August 2...

Read more

31 Jul 202414:25

News

Concord Biotech to conduct AGM

Concord Biotech announced that the 39th Annual General Meeting (AGM) of the company will b...

Read more

31 May 202416:57

News

Volumes spurt at Concord Biotech Ltd counter

Inox Wind Ltd, Sumitomo Chemical India Ltd, Doms Industries Ltd, Natco Pharma Ltd are amon...

Read more

28 May 202414:30

News

Board of Concord Biotech recommends final dividend

Concord Biotech announced that the Board of Directors of the Company at its meeting held o...

Read more

23 May 202419:01

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week High of Concord Biotech Ltd

What is the significance of Concord Biotech Ltd reaching its 52-week high?

Concord Biotech Ltd reaching its 52-week high indicates strong market confidence and a positive outlook on the company's financial health and growth prospects. This milestone often reflects successful business performance and can boost investor sentiment.

Why do investors monitor Concord Biotech Ltd 52-week high?

Investors monitor Concord Biotech Ltd 52-week high to gauge the stock's peak performance and overall market strength, which can indicate robust financial health and growth potential. It also helps them assess if the stock is trading near its maximum value, influencing decisions on buying, holding, or selling.

Is Concord Biotech Ltd a good buy when it hits its 52-week high?

Whether Concord Biotech Ltd is a good buy at its 52-week high depends on various factors, including the company's future growth prospects, overall market conditions, individual investment strategies, and other important Concord Biotech Ltd fundamentals.

What should I consider before investing in Concord Biotech Ltd at its 52-week high?

Before investing in Concord Biotech Ltd at its 52-week high, consider evaluating the company's recent financial performance, growth potential, and overall market conditions to ensure it aligns with your investment goals. Additionally, assess whether the stock's current valuation justifies the potential for future returns and if it fits your risk tolerance.

Can Concord Biotech Ltd stock price continue to rise after reaching its 52-week high?

Concord Biotech Ltd stock price can continue to rise after reaching its 52-week high if it maintains strong fiscal performance and favorable market conditions. However, future growth depends on numerous factors such as company earnings, industry trends, and broader economic conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*